Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228
Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
325

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Antibiotic resistance profiles of oral flora in hippopotami (Hippopotamus amphibius): implications for treatment of human bite wound infections.

One health outlook·2025
Same author

Anti-phenolic glycolipid antibodies in <i>Mycobacterium bovis</i> infected cattle.

One health (Amsterdam, Netherlands)·2025
Same author

Are there benefits of culture-based detection of Mycobacterium avium spp paratuberculosis over histopathology?

The Onderstepoort journal of veterinary research·2025
Same author

Optimization and Application of Real-Time qPCR Assays in Detection and Identification of Chlamydiales in Products of Domestic Ruminant Abortion.

Pathogens (Basel, Switzerland)·2023
Same author

Approaches to increase recovery of bacterial and fungal abortion agents in domestic ruminants.

The Onderstepoort journal of veterinary research·2023
Same author

Prevalence of bovine tuberculosis and characterization of the members of the Mycobacterium tuberculosis complex from slaughtered cattle in Rwanda.

PLoS neglected tropical diseases·2022

関連する実験動画

Updated: Jun 29, 2025

Application of Long-term cultured Interferon-&#947; Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.2K

牛の結核の予防接種

Anita L Michel1

  • 1Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.

Science (New York, N.Y.)
|March 28, 2024
PubMed
まとめ

長年の牛病は 制御が困難であることが証明されています しかし,研究によると,バチルス・カルメッテ・ゲーリン (BCG) ワクチンは,この持続的な動物保健の課題の改善に寄与していることが示されています.

科学分野:

  • 獣医学
  • 感染症
  • 免疫学

背景:

  • 牛の病気は,世界的に大きな経済と健康上の課題をもたらします.
  • この特定の老年牛の病気に対する既存の制御戦略は,限られた有効性を示しています.
  • 新しく効果的な介入が不可欠です

研究 の 目的:

  • 牛の慢性疾患の制御におけるバチルス・カルメッテ・ゲーリン (BCG) ワクチンの可能性を評価する.
  • 代替的または補足的な予防策としてBCGワクチン接種の有効性を評価する.

主な方法:

  • 研究は [実験的なワクチン接種試験,フィールド研究など] を含む.
  • ワクチン接種と対照群の疾患発生率と重症度に関するデータを収集し,分析した.

主要な成果:

  • BCGワクチン接種は,従来の方法と比較して,改善されたコントロールを提供することを予見する.
  • BCGワクチンを接種した牛の病気の流行や重症度が減少した.

結論:

  • BCGワクチンは この困難な牛の病気を 制御する有望な手段です
  • 牛の健康管理におけるBCGの役割を確認し,最適化するために,さらなる研究とフィールドアプリケーションが必要である.

さらに関連する動画

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

971
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K

関連する実験動画

Last Updated: Jun 29, 2025

Application of Long-term cultured Interferon-&#947; Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.2K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

971
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K